Skip to main navigation
Skip to search
Skip to main content
Experts@Syracuse Home
Help & FAQ
Home
Profiles
Research units
Research output
Equipment
Grants
Activities
Press and Media
Prizes
Search by expertise, name or affiliation
Tri-Agonist for the GLu, GLP-1 and NPY2 Receptors
Robert Doyle
(Inventor)
Department of Chemistry
Research output
:
Patent
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Tri-Agonist for the GLu, GLP-1 and NPY2 Receptors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glucagon-like peptide-1 (GLP-1)
100%
Weight Loss
100%
Appetite Regulation
50%
Glucagon-like
50%
A1 Receptor
50%
Type 2 Diabetic Patients
50%
Neuropeptide Y2 Receptor
50%
Glucoregulation
50%
Glucagon Receptor
50%
Chemistry
Neuropeptide
100%
Immunology and Microbiology
Agonist
100%
Agricultural and Biological Sciences
Glucoregulation
50%
Glucagon Receptor
50%
Biochemistry, Genetics and Molecular Biology
Glucagon Receptor
50%